SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD

SueWallSt (Levi & Korsinsky) issued a lead-plaintiff-deadline reminder for a securities class action against Aardvark Therapeutics covering purchases between February 13, 2025 and May 14, 2026, with a deadline of October 13, 2026. The complaint alleges AARD's IPO and SEC filings overstated ARD-101's safety, describing it as roughly 99% gut-restricted with no serious adverse events, despite cardiac safety issues that later triggered a Phase 3 HERO trial pause and a full FDA clinical hold.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.